EQT CEO Christian Sinding highlighted our investment approach on the CNBC morning show Squawk Box.
Galderma, the pure-play dermatology category leader, goes public on the SIX Swiss Exchange
EQT AB publishes Annual and Sustainability Report for 2023
EQT Life Sciences portfolio company Amolyt Pharma to be acquired by AstraZeneca for up to USD 1.05 billion
EQT Life Sciences Leads Tubulis’ Upsized €128 Million Series B2 Financing
EQT Private Equity to sell its 20% stake in Ottobock, the global leader in wearable human bionics
Sir Alok Sharma joins the EQT Network as Senior Advisor
EQT recognised in the 2023 PEI Group Awards
EQT AB hosts Capital Markets Day
Galderma, an EQT Private Equity portfolio company, announces its intention to conduct an Initial Public Offering
EQT Future holds final close; over EUR 25 billion (USD 27 billion) raised across EQT Private Equity in fundraisings concluded during 2024 to-date
